4
Changes in Ownership
GALECTIN THERAPEUTICS INC Filed Acc 0000899243-21-013816
Options or other derivatives
- Chief Medical Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Boudes Pol F · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-25 | Grant or award : show line 1 in the form Stock option (right to buy) | +50,000 | $2.11 | 2031-03-25 | 50,000 | 50,000 | D |
| 2021-03-25 | Grant or award : show line 2 in the form Stock option (right to buy) | +100,000 | $2.11 | 2031-03-25 | 100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…